{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:58:59Z","timestamp":1761746339892,"version":"build-2065373602"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,2]],"date-time":"2002-01-02T00:00:00Z","timestamp":1009929600000},"content-version":"vor","delay-in-days":488,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    To measure free\u200a:\u200atotal prostate specific antigen (PSA) ratios in ejaculate from men with suspected and known prostate cancer, and in young control men, to determine if this ratio might be useful in discriminating benign from malignant prostatic conditions.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Patients, subjects and methods<\/jats:bold>\n                    Forty\u2010seven men with prostate cancer (positive biopsies), 52 men with suspected prostate cancer but who had negative biopsies and 28 young men (&lt;\u200330\u2003years old) and with no family history of cancer, provided either a single ejaculate specimen (total 59) or multiple specimens (total 193) on subsequent occasions. Free and total PSA were measured using appropriate assays. All specimens were diluted in a PSA\u2010negative female serum pool.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    The median free\u200a:\u200atotal PSA ratios were 0.76\u20130.81 among the patient groups and control men, and there was no statistical difference between the groups. These data presumably only reflect the inactive component of free PSA, given that any \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010macroglobulin or \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    \u2010antichymotrypsin in the assay serum diluent was likely to have bound the active free PSA component in these samples. Similar results were obtained from those providing single and multiple samples, suggesting that a single specimen is sufficient to reflect the seminal plasma free\u200a:\u200atotal PSA ratio over that period. There was no relationship between seminal plasma free\u200a:\u200atotal PSA ratio and age for the controls or the positive biopsy group, although there was a negative relationship (i.e. a decline with age) that almost reached significance in those with negative biopsies (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.058,\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2003=\u20030.07).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    This is the first report of free\u200a:\u200atotal PSA ratios in the ejaculate of men with suspected and known prostate cancer compared with young control men. Although no significant changes were detected in the free\u200a:\u200atotal PSA ratios in ejaculate, these results may be confounded by differences in ratios with age, as is the case for serum PSA or different molecular forms of PSA. Indeed, these data suggest that a large proportion of free PSA in seminal plasma may be inactive. Further studies are needed to determine the potential utility of measuring free\u200a:\u200atotal PSA, or other candidate markers, in ejaculate to better discriminate benign from malignant prostate disease.\n                  <\/jats:p>","DOI":"10.1046\/j.1464-410x.2000.00835.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T02:56:33Z","timestamp":1047351393000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inactive free\u200a:\u200atotal prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men"],"prefix":"10.1111","volume":"86","author":[{"given":"J.A.","family":"Clements","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"DeVoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hamlyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Scells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yaxley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,2]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_6_2_2","DOI":"10.1016\/S0022-5347(17)32422-9"},{"key":"e_1_2_6_3_2","first-page":"222","article-title":"A complex between prostate\u2010specific antigen and alpha 1\u2013chymotrypsin is the major form of prostate\u2010specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer","volume":"51","author":"Stenman UH","year":"1991","journal-title":"Cancer Res"},{"doi-asserted-by":"publisher","key":"e_1_2_6_4_2","DOI":"10.1016\/S0022-5347(17)35408-3"},{"doi-asserted-by":"publisher","key":"e_1_2_6_5_2","DOI":"10.1046\/j.1464-410X.1996.00095.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_6_2","DOI":"10.1016\/s0090-4295(98)90059-0"},{"doi-asserted-by":"publisher","key":"e_1_2_6_7_2","DOI":"10.1006\/scbi.1998.0086"},{"doi-asserted-by":"publisher","key":"e_1_2_6_8_2","DOI":"10.1016\/S0090-4295(97)00178-7"},{"doi-asserted-by":"publisher","key":"e_1_2_6_9_2","DOI":"10.1016\/S0022-5347(01)67444-5"},{"doi-asserted-by":"publisher","key":"e_1_2_6_10_2","DOI":"10.1016\/S0022-5347(17)35304-1"},{"doi-asserted-by":"publisher","key":"e_1_2_6_11_2","DOI":"10.1016\/S0090-4295(99)80451-8"},{"doi-asserted-by":"publisher","key":"e_1_2_6_12_2","DOI":"10.1046\/j.1464-410X.1996.00089.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_13_2","DOI":"10.1002\/(sici)1097-0045(19980801)36:3<181::aid-pros6>3.0.co;2-k"},{"doi-asserted-by":"publisher","key":"e_1_2_6_14_2","DOI":"10.1016\/S0022-5347(01)61680-X"},{"doi-asserted-by":"publisher","key":"e_1_2_6_15_2","DOI":"10.1080\/10408369891234219"},{"doi-asserted-by":"publisher","key":"e_1_2_6_16_2","DOI":"10.1172\/JCI113070"},{"doi-asserted-by":"publisher","key":"e_1_2_6_17_2","DOI":"10.1002\/j.1939-4640.1999.tb02528.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_18_2","DOI":"10.1097\/00005392-199907000-00022"},{"doi-asserted-by":"publisher","key":"e_1_2_6_19_2","DOI":"10.1093\/oxfordjournals.humrep.a019136"},{"doi-asserted-by":"publisher","key":"e_1_2_6_20_2","DOI":"10.1016\/s0090-4295(98)00550-0"},{"doi-asserted-by":"publisher","key":"e_1_2_6_21_2","DOI":"10.1080\/014850199262850"},{"doi-asserted-by":"publisher","key":"e_1_2_6_22_2","DOI":"10.1016\/S0022-2143(98)90183-4"},{"doi-asserted-by":"publisher","key":"e_1_2_6_23_2","DOI":"10.1016\/S0090-4295(97)00108-8"},{"key":"e_1_2_6_24_2","first-page":"455","article-title":"Immuno\u2010histochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate\u2010specific antigen) in the functional analysis of human prostate tumours","volume":"150","author":"Tremblay RR","year":"1997","journal-title":"Am J Pathol"},{"doi-asserted-by":"publisher","key":"e_1_2_6_25_2","DOI":"10.1159\/000067994"},{"key":"e_1_2_6_26_2","first-page":"2629","article-title":"Age related changes of free and total prostate specific antigen in serum","volume":"19","author":"Wolff JM","year":"1999","journal-title":"Anticancer Res"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/clinchem\/44.4.895a","article-title":"Letter: PSA estimations in seminal plasma","volume":"44","author":"Wang TJ","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/clinchem\/44.1.191","article-title":"Analytical characteristics of seminal fluid PSA differ from those of serum PSA","volume":"44","author":"Tewari PC","year":"1998","journal-title":"Clin Chem"},{"doi-asserted-by":"publisher","key":"e_1_2_6_29_2","DOI":"10.1016\/S0022-5347(01)64704-9"},{"doi-asserted-by":"publisher","key":"e_1_2_6_30_2","DOI":"10.1016\/S0022-5347(01)64289-7"},{"doi-asserted-by":"publisher","key":"e_1_2_6_31_2","DOI":"10.1159\/000020006"},{"doi-asserted-by":"publisher","key":"e_1_2_6_32_2","DOI":"10.1111\/j.1432-1033.1994.tb18597.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_33_2","DOI":"10.1016\/S0022-5347(01)64085-0"},{"doi-asserted-by":"publisher","key":"e_1_2_6_34_2","DOI":"10.1016\/S0065-1281(84)80005-7"},{"doi-asserted-by":"publisher","key":"e_1_2_6_35_2","DOI":"10.1016\/0090-4295(94)90225-9"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/clinchem\/43.2.352","article-title":"Two\u2010dimensional gel electrophoresis detects prostate\u2010specific antigen\u2010\u03b11\u2010antichymotrypsin complex in serum but not prostatic fluid","volume":"43","author":"Qian Y","year":"1997","journal-title":"Clin Chem"},{"doi-asserted-by":"publisher","key":"e_1_2_6_37_2","DOI":"10.1016\/S0090-4295(96)00607-3"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1464-410X.2000.00835.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1464-410X.2000.00835.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:32:20Z","timestamp":1761733940000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1046\/j.1464-410X.2000.00835.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1464-410X.2000.00835.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00835.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2002-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}